Cargando…
Abnormal myocardial enzymes in the prediction of mortality and hypertension in COVID-19 patients: a retrospective study
This study aims to determine the differences in myocardial enzymes in COVID-19 patients with and without hypertension. A total of 130 patients with COVID-19 in Yunmeng County People's Hospital were analyzed. The clinical manifestations and laboratory indicators were collected and analyzed. We f...
Autores principales: | Sha, Shuang, Liu, Min, Sun, Miaomiao, Xiao, Long, Chang, Qing, Chen, Ying, Huang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699763/ https://www.ncbi.nlm.nih.gov/pubmed/36326681 http://dx.doi.org/10.18632/aging.204362 |
Ejemplares similares
-
Association of Myocardial Enzyme Abnormality with Clinical Outcomes of Patients with COVID-19: A Retrospective Study
por: Zhang, Qilin, et al.
Publicado: (2021) -
The predictive value of Cardiodynamicsgram in myocardial perfusion abnormalities
por: Dong, Xunde, et al.
Publicado: (2018) -
Predictive value of incidental right ventricular abnormalities identified on SPECT for mortality and pulmonary hypertension
por: Jose, Arun, et al.
Publicado: (2021) -
Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients
por: Cheng, Jingping, et al.
Publicado: (2021) -
Empagliflozin improves chronic hypercortisolism-induced abnormal myocardial structure and cardiac function in mice
por: Zhang, Qing-Qing, et al.
Publicado: (2020)